Skip to main content
Addgene

HA-HIF2α MT-pBabe-Hygro
(Plasmid #22134)

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 22134 Standard format: Plasmid sent in bacteria as agar stab 1 $85

Backbone

  • Vector backbone
    pBabe-Hygro
  • Backbone size w/o insert (bp) 5573
  • Vector type
    Mammalian Expression, Retroviral
  • Selectable markers
    Hygromycin

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    DH5alpha
  • Growth instructions
    DH5alpha BL21
  • Copy number
    High Copy

Gene/Insert

  • Gene/Insert name
    Hypoxia inducible factor 2 alpha
  • Alt name
    HIF2a
  • Alt name
    EPAS1
  • Species
    H. sapiens (human)
  • Insert Size (bp)
    2639
  • Mutation
    cDNA "silent"("conservative") mutations: GGAGACGGAGGTGTTCTAT mutated to GGAGACCGAAGTCTTCTAT to render cDNA resistant to siRNA #3: 5’-GGAGACGGAGGTGTTCTAT-3’
  • GenBank ID
    NM_001430
  • Entrez Gene
    EPAS1 (a.k.a. ECYT4, HIF2A, HLF, MOP2, PASD2, bHLHe73)
  • Tag / Fusion Protein
    • HA-tag (N terminal on backbone)

Cloning Information

  • Cloning method Restriction Enzyme
  • 5′ cloning site BamH I (not destroyed)
  • 3′ cloning site EcoR I (destroyed during cloning)
  • 5′ sequencing primer pBabe-5'
  • 3′ sequencing primer pBabe-3'
  • (Common Sequencing Primers)

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    HA-HIF2α MT-pBabe-Hygro was a gift from William Kaelin (Addgene plasmid # 22134 ; http://n2t.net/addgene:22134 ; RRID:Addgene_22134)
  • For your References section:

    Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth. Kondo K, Kim WY, Lechpammer M, Kaelin WG. PLoS Biol. 2003 Dec . 1(3):E83. 10.1371/journal.pbio.0000083 PubMed 14691554